Ti((i)OPr)(4) was treated with 2.58 equiv of hydroquinone in THF to yield a red-orange powder formulated as [Ti(OC(6)H(4)O)(a)()(OC(6)H(4)OH)(3.34)(-)(1.83)(a)()(O(i)Pr)(0.66)(-)(0.17)(a)() (THF)(0.2)](n)() (1, (0.91 </= a </= 1.82)) based upon D(2)O/DCl quenching studies. Treatment of 1 with an excess of hydroquinone in Et(2)O or DME afforded burgundy [Ti(2)((1,4)-OC(6)H(4)O)(2)((1,4)-OC(6)H(4)OH)(2)(-OC(6)H(4)OH)(2)](infinity) (2). Burgundy [Ti(2)((1,4)-OC(6)H(4)O)(2)((1,4):eta(2),eta(1)-OC(6)H(4)O)(2)(OH(2))(2).(H(2)O)(2).(H-OC(6)H(4)OH).(MeCN)](infinity) (4) was prepared from 1 and excess wet hydroquinone in CH(3)CN. The acetonitrile in 4 can be exchanged for THF or DME. Treatment of Ti(O(i)Pr)(4) with approximately 4 equiv of 2,7-dihydroxynaphthalene in Et(2)O at 100 degrees C (2 days) in a sealed tube yielded orange crystals of [Ti(2)((1,7)-OC(10)H(6)O)(2)((1,7):eta(2),eta(1)-OC(10)H(6)OH)(2)(O(i)Pr)(2)](infinity) (5). Diffraction studies were conducted at the Cornell High Energy Synchrotron Source (CHESS) because of the small crystal sizes. 2 (C(18)H(14)O(6)Ti, monoclinic, P2(1)/n, a = 9.624 (2), b = 11.283 (2), c = 14.916 (3), beta = 90.47(3) degrees, Z = 4), 4 (C(32)H(33)NO(14)Ti(2), monoclinic, P2(1)/n, a = 16.137 (3), b = 10.762 (2), c = 20.368 (4), beta = 111.65(3) degrees, Z = 4), and 5 (C(23)H(20)O(5)Ti, orthorhombic, Pbca, a = 11.095 (2), b = 17.970 (4), c = 19.484 (4), Z = 8) are 3-dimensional materials based on diaryloxide connectivity between geometrically similar edge shared (i.e., Ti(2)(-OAr)(2)) bioctahedral dititanium building blocks. While 2 and 5 possess a roughly body-centered arrangement of dititanium units, 4 has a hexagonal secondary structural motif. The nature of crystallization through alcoholysis is also discussed.
No takes yet. Share an insight, caveat, or question.
Vaid et al. (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: